Compare ARK Genomic Revolution ETF (ARKG) vs Hyatt Hotels Corporation (H) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Hyatt Hotels Corporation — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Hyatt Hotels Corporation trades at $190.5 (market cap $18.00B). The key difference: Hyatt Hotels Corporation pays a 0.31% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | H | |
|---|---|---|
Sector | Sector/Thematic | Consumer Cyclical |
52-Week High | $43.57 | $202.09 |
52-Week Low | $23.09 | $135.01 |
Market Cap | — | $18.00B |
Enterprise Value | — | $21.84B |
Dividend Yield | — | 0.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Hyatt Hotels Corp (H) trades at $191.14, up 0.63% on the day, with a bearish technical signal but mixed earnings performance. Recent quarters show beats on EPS estimates, though net income margin remains negative at -0.48%. The company announced expansion plans, including a new Hyatt Regency in Tucson, amid stable revenue around $7.1B. Cash flow trends indicate operational challenges, with net cash flow turning negative in 2025.
Outlook is cautious with analyst consensus tilted toward Hold (52.08%). Upside exists if operational efficiency improves and travel demand sustains, but risks include high debt levels and profitability pressures. The stock trades near the consensus price target of $197.30, suggesting limited near-term upside without fundamental catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Hyatt Hotels Corporation
Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →
